CFSAN program priorities
This article was originally published in The Tan Sheet
Executive Summary
Pearson v. Shalala agency response strategy added to the center's "A-List" of priorities to be tackled in 1999, center Director Joseph Levitt says in an attachment to a July 2 "Dear Colleague" letter. Under the Jan. 15 federal appeals court decision, the agency must clarify the "significant scientific agreement" standard for health claims and reconsider whether four specific supplement health claims previously denied by FDA should be allowed with appropriate labeling disclaimers. FDA declined to appeal the decision to the Supreme Court (1"The Tan Sheet" July 5, In Brief)